Trial intelligence / Profile preview

Four topical vaginal therapies for urogenital atrophy in postmenopausal women

RBR-2wjrp4Not yet recruiting

Sponsor
Hospital da Mulher Prof. Dr. José Aristodemo Pinotti - CAISM
Start
Jan 2012
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Randomised trial of DehydraTECH-estrogen, testosterone, carbomer and Placebo-COD Research Private Ltd in vaginal atrophy (4 arms), sponsored by Hospital da Mulher Prof. Dr. José Aristodemo Pinotti - CAISM. Planned start Jan 2012; status: not yet recruiting.

02

Drugs

DehydraTECH-estrogentestosteronecarbomerPlacebo-COD Research Private Ltd
03

Conditions

vaginal atrophy

Beyond the preview

Go deeper on RBR-2wjrp4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-2wjrp4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call